These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors. Mertz LE; Blair JE Ann N Y Acad Sci; 2007 Sep; 1111():343-57. PubMed ID: 17363440 [TBL] [Abstract][Full Text] [Related]
5. Coccidioidomycosis in non-endemic areas: a case series. Desai SA; Minai OA; Gordon SM; O'Neil B; Wiedemann HP; Arroliga AC Respir Med; 2001 Apr; 95(4):305-9. PubMed ID: 11316114 [TBL] [Abstract][Full Text] [Related]
6. Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Carvalho C; Ferreira I; Gaião S; Guimarães S; Costa R; Santos J; Sampaio S; Bustorff M; Oliveira G; Pestana M Transpl Infect Dis; 2010 Apr; 12(2):151-4. PubMed ID: 19765265 [TBL] [Abstract][Full Text] [Related]
7. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Nishikubo CY; Kunkel LA; Figlin R; Belldegrun A; Rosen P; Elashoff R; Wang H; Territo MC Cancer; 1996 Dec; 78(11):2421-6. PubMed ID: 8941014 [TBL] [Abstract][Full Text] [Related]
8. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series. Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746 [TBL] [Abstract][Full Text] [Related]
9. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)]. Jakó J; Szerafin L; Nagy P Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344 [TBL] [Abstract][Full Text] [Related]
10. The prevention of recrudescent coccidioidomycosis after solid organ transplantation. Blair JE; Kusne S; Carey EJ; Heilman RL Transplantation; 2007 May; 83(9):1182-7. PubMed ID: 17496533 [TBL] [Abstract][Full Text] [Related]
11. Coccidioidomycosis in patients with diabetes mellitus. Santelli AC; Blair JE; Roust LR Am J Med; 2006 Nov; 119(11):964-9. PubMed ID: 17071165 [TBL] [Abstract][Full Text] [Related]
12. Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies. Tam C; Seymour JF; Brown M; Campbell P; Scarlett J; Underhill C; Ritchie D; Bond R; Grigg AP Haematologica; 2005 May; 90(5):700-2. PubMed ID: 15921393 [TBL] [Abstract][Full Text] [Related]
13. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Keckich DW; Blair JE; Vikram HR; Seville MT; Kusne S Transplantation; 2011 Jul; 92(1):88-93. PubMed ID: 21516063 [TBL] [Abstract][Full Text] [Related]
14. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Tsai MS; Kuo CY; Wang MC; Wu HC; Chien CC; Liu JW J Microbiol Immunol Infect; 2006 Apr; 39(2):150-4. PubMed ID: 16604248 [TBL] [Abstract][Full Text] [Related]
15. Late non-relapse mortality among adult autologous stem cell transplant recipients: a nation-wide analysis of 1,482 patients transplanted in 1990-2003. Jantunen E; Itälä M; Siitonen T; Koivunen E; Leppä S; Juvonen E; Kuittinen O; Lehtinen T; Koistinen P; Nyman H; Nousiainen T; Volin L; Remes K Eur J Haematol; 2006 Aug; 77(2):114-9. PubMed ID: 16856906 [TBL] [Abstract][Full Text] [Related]
16. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460 [TBL] [Abstract][Full Text] [Related]
17. State-of-the-art treatment of coccidioidomycosis: skin and soft-tissue infections. Blair JE Ann N Y Acad Sci; 2007 Sep; 1111():411-21. PubMed ID: 17332079 [TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related]
19. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Rizzieri DA; Feldman E; Dipersio JF; Gabrail N; Stock W; Strair R; Rivera VM; Albitar M; Bedrosian CL; Giles FJ Clin Cancer Res; 2008 May; 14(9):2756-62. PubMed ID: 18451242 [TBL] [Abstract][Full Text] [Related]